Transcripts Aligos Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-01 EDT			5-day change	1st Jan Change
6.090 ^USD	+3.92%		-12.12%	-34.66%

08-12	Aligos Therapeutics Initiates Dosing in Phase 1 Study of Alg-170675 for Chronic Hepatitis B Virus Infection	CI
08-06	Aligos Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

11-20	Aligos Therapeutics, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-17-2025 03:00 PM
21-01-11	Aligos Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 12:40 PM

No results match your criteria